These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10828759)

  • 21. Therapeutic resistance to ACEI and ARB combination in macroalbuminuric diabetic nephropathy.
    Futrakul N; Futrakul P
    Clin Nephrol; 2012 Sep; 78(3):250. PubMed ID: 22541688
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal damage associated with proteinuria.
    Praga M; Morales E
    Kidney Int Suppl; 2002 Dec; (82):S42-6. PubMed ID: 12410854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ; Song JH; Suh JH; Lee SW; Kim GA
    Yonsei Med J; 2003 Jun; 44(3):463-72. PubMed ID: 12833584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
    Cetinkaya R; Odabas AR; Selcuk Y
    Int J Clin Pract; 2004 May; 58(5):432-5. PubMed ID: 15206496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG; Balestracci A; Missoni M; Vezzani C
    Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
    Buter H; Hemmelder MH; Navis G; de Jong PE; de Zeeuw D
    Nephrol Dial Transplant; 1998 Jul; 13(7):1682-5. PubMed ID: 9681711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
    Wapstra FH; Van Goor H; Navis G; De Jong PE; De Zeeuw D
    Clin Sci (Lond); 1996 May; 90(5):393-401. PubMed ID: 8665777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.
    de Zeeuw D; Heeg JE; Stelwagen T; de Jong RJ; de Jong PE
    Contrib Nephrol; 1990; 83():160-5. PubMed ID: 1966072
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of angiotensin-converting-enzyme inhibition in patients with renal disease.
    Manley HJ
    Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S12-8. PubMed ID: 11030018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
    Kuriyama S; Tomonari H; Abe A; Imasawa T; Hosoya T
    Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
    [No Abstract]   [Full Text] [Related]  

  • 36. Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
    Vogt L; Navis G; de Zeeuw D
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S53-7. PubMed ID: 15938035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
    Agarwal R; Siva S; Dunn SR; Sharma K
    Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F; Chiodini P; De Nicola L; Minutolo R; Zamboli P; Gallo C; Conte G
    Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.